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Introduction {#sec005}
============

Coronary artery bypass grafting (CABG) procedures are the most common open heart procedure performed in most heart surgery centres. The standard of care using the left internal thoracic artery (LITA) as a single arterial graft was outlined in the mid-eighties by Loop et al. who showed better long--term patency of a LITA graft to left anterior descending (LAD) compared to that of a saphenous vein graft (SVG) connected to the LAD \[[@pone.0224310.ref001]\]. Several studies demonstrated a reduction in long-term mortality following bilateral internal thoracic arteries (BITA) compared to single internal thoracic artery (SITA) \[[@pone.0224310.ref002]--[@pone.0224310.ref006]\].

Several prediction models for long term survival after CABG have been proposed over the last years \[[@pone.0224310.ref007]--[@pone.0224310.ref015]\]. However, these models usually referred to long term survival as survival of up to 5 years \[[@pone.0224310.ref008]--[@pone.0224310.ref011], [@pone.0224310.ref013], [@pone.0224310.ref015]\], while only a few observed 7 or 8-year survival \[[@pone.0224310.ref007], [@pone.0224310.ref014], [@pone.0224310.ref012]\]. To the best of our knowledge, no study has published a model predicting survival beyond this period. Moreover, none of these models were built specifically for BITA grafting.

The main objective of the present study was to identify predictors for long term survival after BITA grafting and to build a simple validated prediction tool.

Methods {#sec006}
=======

Study design {#sec007}
------------

Historical cohort study.

Setting {#sec008}
-------

A 24-bed cardio-thoracic surgery department located at the Tel Aviv Sourasky Medical Center, a university affiliated 1500-bed medical center. The medical center is located in the center of Israel and serves a population of nearly 1 million people. The Tel Aviv Sourasky Medical Center ethics committee approved the study and waived the requirement for informed consent (number 0827-18-TLV).

Participants {#sec009}
------------

All patients who underwent CABG using two ITAs between January 1996 and December 2011 were included in the study. Patients who underwent concomitant procedures were excluded from the study.

In our department the use of BITA grafting has been the standard of care since 1996 \[[@pone.0224310.ref016]\], and is employed for all patients unless the patient has single vessel disease, increased risk of sternal wound infection (mostly female patients with combination of diabetes and obesity), or the consensus among senior staff is that the patient is too sick to undergo BITA grafting.

Variables {#sec010}
---------

Data on patients\' characteristics were recorded at the time of admission. Demographic data (age and sex); comorbidities: diabetes mellitus (DM), chronic obstructive lung disease (COPD), chronic renal failure (CRF), peripheral and cerebral-vascular disease (PVD, CVD), and any neurologic dysfunction (ND); cardiac characteristics: congestive heart failure (CHF), old and acute myocardial infarction (MI), unstable angina, severely reduced ejection fraction (EF), previous percutaneous transluminal coronary angioplasty (PCI), 3 or more diseased vessels, and left main disease (LM); patient\'s status: need of pre-operative intra-aortic balloon (IABP), emergency operation, and critical pre-operative status; and surgical characteristics: repeated operation, 3 or more bypass grafts, sequential grafts, the use of saphenous vein grafts, gastro-epiploic, radial grafts, grafts to the right coronary system and the use of off-pump technique, were collected. Old and acute myocardial infarction (MI) were considered as MI more than 7 days before surgery, and MI within the week before the surgery, respectively. Severely reduced ejection fraction was considered as ejection fraction equal or less than 30%. Critical pre-operative status was defined as the status of a patient who needed ventilation or IABP support or inotropic support, or any combination thereof before surgery. Emergency surgery was a surgery performed within the first week after cardiac catheterization due to the patient\'s condition. Mortality was defined as all-cause mortality occurring up to 15 years after surgery.

Data sources {#sec011}
------------

All data was collected from patient files and hospital databases by residents or senior physicians. Late mortality was collected from the Israeli Internal Affairs Office National Registry Database.

Bias {#sec012}
----

All residents and senior physicians were instructed by one of the researchers (Mohr R) on the data collection in order to minimize collection bias and all data were recorded into an Excel file.

Sample size {#sec013}
-----------

Sample size was calculated according to log-rank test using significance level of 0.5% and power of 90%. The hazard ratio was set to 1.5 and survival at the end of follow-up was considered as 60%. According to these parameters, 1,046 patients were needed to identify predictors for mortality and to build the prediction model.

Quantitative variables {#sec014}
----------------------

Age was divided into 5-year categories in order to simplify the use of the prediction model.

Statistical methods {#sec015}
-------------------

Categorical variables were reported as number and percentage. Age was reported as mean and standard deviation (SD). Median and interquartile range of the surgery period was also reported. Length of follow-up was observed using reverse censoring method. Study population was randomly divided into two equal size groups. One group was used to identify predictors for mortality and to build the prediction model (learning group) and the second group was used to validate the model (validation group). The characteristics of the two groups were compared in order to evaluate the randomization. Chi-square test, independent samples T test, and Mann Whitney test were used to compare the characteristics between groups. Log-rank test was used to compare survival between groups.

Multivariable cox regression using backward method (likelihood ratio was used as criteria and p\>0.1 was set as threshold value for removal). Demographic data, comorbidities, cardiac characteristics, and patients\' status were included in the multivariable cox regression. Nomogram was built in order to introduce a simple tool for prediction of 5, 10, and 15-year survival. We also evaluated the baseline hazard at these time points and reported the coefficients of the variables that were included in the final model.

Calibration plots (predicted vs. observed values) were drawn in order to evaluate the prediction model. A predicted value indicates the predicted survival probability at a single time point, and observed value refers to the corresponding Kaplan-Meier survival estimate.

Harrell\'s concordance (C) statistic was used to evaluate the overall model discrimination ability. The area under the receiver operating characteristics curve was used to evaluate the discrimination ability of the model at these time points in both the learning and validation groups.

All statistical tests were two sided and p\<0.05 was considered as statistically significant. SPSS (IBM SPSS Statistics for Windows, version 24, IBM corp., Armonk, NY, USA, 2016) and R (version 3.5.1, R Foundation for Statistical Computing, Vienna, Austria, 2018) were used for all statistical analysis. The following \"R\" packages were used: "rms" package (Harrell FE Jr. rms: Regression Modeling Strategies, ver. 5.1--2), "survival" package (Therneau TM. survival:Survival Analysis, ver. 2.42--6), \"prodlim\" package (Gerds TA. prodlim:Product-Limit Estimation for Censored Event History Analysis, ver. 2018.04.18), \"dynpred\" package (Putter H. Companion Package to \"Dynamic Prediction in Clinical Survival Analysis\", ver. 0.1.2), and \"survivalROC\" package (Heagerty PJ. survivalROC:Time-dependent ROC curve estimation from censored survival data, ver. 1.0.3).

Results {#sec016}
=======

The study cohort included 2,935 patients who underwent BITA grafting between 1996 and 2011 (median January 2001). The median follow-up time was 15 years (IQR 12--15). One thousand four hundred and sixty eight patients were included in the learning group and 1,467 in the validation group. Comparisons of patients\' characteristics are presented in [Table 1](#pone.0224310.t001){ref-type="table"}.

10.1371/journal.pone.0224310.t001

###### Comparison of patients\' characteristics between the learning and the validation groups.

![](pone.0224310.t001){#pone.0224310.t001g}

                                        Group                              
  ------------------------------------- ------------------- -------------- -------
  [Demographic characteristics]{.ul}:                                      
  Male                                  1194 (81.3%)        1214 (82.8%)   0.317
  Age (years), mean (SD)                65.2 (10.5)         65.3 (10.6)    0.851
  Period, median (IQR)                  12/2000             03/2001        0.258
  (03/1998-01/2005)                     (04/1998-03/2005)                  
  [Comorbidities]{.ul}:                                                    
  DM                                    495 (33.7%)         506 (34.5%)    0.659
  DM EOD                                88 (6.0%)           93 (6.3%)      0.698
  COPD                                  77 (5.2%)           68 (4.6%)      0.446
  CRF                                   105 (7.2%)          99 (6.7%)      0.667
  PVD                                   262 (17.8%)         274 (18.7%)    0.561
  CVD                                   142 (9.7%)          134 (9.1%)     0.617
  ND                                    64 (4.4%)           51 (3.5%)      0.218
  [Cardiac characteristics]{.ul}:                                          
  CHF                                   305 (20.8%)         308 (21%)      0.884
  Old MI                                575 (39.2%)         540 (36.8%)    0.188
  Acute MI                              278 (18.9%)         297 (20.2%)    0.372
  UAP                                   824 (56.1%)         772 (52.6%)    0.057
  EF ≤ 30%                              109 (7.4%)          85 (5.8%)      0.075
  NOVS ≥ 3                              1014 (69.1%)        1131 (77.1%)   0.439
  LM                                    479 (32.6%)         457 (31.2%)    0.391
  PTCA                                  231 (15.7%)         246 (16.8%)    0.448
  [Patient\'s status]{.ul}:                                                
  IABP                                  97 (6.6%)           87 (5.9%)      0.449
  Critical                              104 (7.1%)          97 (6.6%)      0.612
  Emergency                             208 (14.2%)         234 (16%)      0.177
  [Surgical characteristics]{.ul}:                                         
  REDO                                  33 (2.2%)           29 (2%)        0.610
  Bypass ≥ 3                            1079 (73.5%)        1122 (76.5%)   0.062
  Sequential                            650 (44.3%)         667 (45.5%)    0.517
  SVG                                   503 (34.3%)         523 (35.7%)    0.431
  GEA                                   179 (12.2%)         174 (11.9%)    0.782
  Right system                          881 (60%)           925 (63.1%)    0.891
  RADIAL                                40 (2.7%)           43 (2.9%)      0.736
  OPCAB                                 356 (24.3%)         328 (22.4%)    0.225

DM---Diabetes mellitus; EOD---End organ damage; COPD---Chronic obstructive lung disease; CRF---Chronic renal failure; PVD---Peripheral vascular disease; CVD--Cerebral vascular disease; ND---Neurologic dysfunction; CHF---Congestive heart failure; MI---Myocardial infarction; UAP---Unstable angina pectoris; EF---Ejection fraction; NOVS--Number of vessels; LM---Left main disease; PTCA---Percutaneous transluminal coronary angioplasty; IABP---Intra-aortic balloon; REDO---Repeated operation; SVG---Saphenous vein graft; GEA---gastro-epiploic graft; OPCAB---Off-pump coronary artery bypass

Six hundred twenty-six (42.6%) patients in the learning group and 593 (40.4%) patients in the validation group died during the follow-up (p = 0.437). The median survival time was not reached over the 15 years of follow up. The cumulative 5, 10, and 15 year survival rates were 0.861, 0.706, and 0.503, respectively for the learning group, and 0.865, 0.716, and 0.526, respectively, for the validation group ([Fig 1](#pone.0224310.g001){ref-type="fig"}).

![Kaplan-Meir curve demonstrating the cumulative survival during the follow-up period in the learning and validation groups.](pone.0224310.g001){#pone.0224310.g001}

In multivariable analysis based on the learning group, older age, diabetes mellitus, COPD, CHF, CRF, old MI, EF≤30%, pre-operative intra-aortic balloon, and PVD were significant predictors for mortality in the learning group ([Table 2](#pone.0224310.t002){ref-type="table"}).

10.1371/journal.pone.0224310.t002

###### Predictors for mortality in the learning group and the multivariable cox regression coefficients.

![](pone.0224310.t002){#pone.0224310.t002g}

  -------------------------------------------------------------
  Predictor     Coefficient   HR (95%CI)              p
  ------------- ------------- ----------------------- ---------
  Age (years)                                         \
                                                      \<0.001

  \<55                        1                       

  55--59        0.5858        1.796 (1.178--2.739)    

  60--64        0.7733        2.167 (1.450--3.238)    

  65--69        1.1821        3.261 (2.260--4.705)    

  70--74        1.3961        4.040 (2.834--5.759)    

  75--79        1.8342        6.258 (4.370--8.962)    

  80+           2.0434        7.700 (5.216--11.366)   

  DM            0.2795        1.323 (1.122--1.559)    0.001

  COPD          0.4283        1.534 (1.127--2.089)    0.007

  CHF           0.2932        1.341 (1.114--1.614)    0.002

  CRF           0.3797        1.460 (1.134--1.880)    0.003

  Old MI        0.2225        1.249 (1.061--1.470)    0.007

  EF≤30%        0.3600        1.433 (1.102--1.863)    0.007

  IABP          0.4476        1.565 (1.169--2.095)    0.003

  PVD           0.4424        1.556 (1.298--1.866)    \<0.001
  -------------------------------------------------------------

The baseline hazards for 5, 10 and 15 years were 0.02689, 0.06678 and 0.14259, respectively.

DM---Diabetes mellitus; COPD---Chronic obstructive lung disease; CHF---Congestive heart failure; CRF---Chronic renal failure; MI---Myocardial infarction; EF---Ejection fraction; IABP---Intra-aortic balloon; PVD---Peripheral vascular disease

The calibration curves of the model presented good calibration at the three time points, in both the learning and validation groups ([Fig 2](#pone.0224310.g002){ref-type="fig"} and [Fig 3](#pone.0224310.g003){ref-type="fig"}).

![Calibration curve of the multivariable cox regression model based on the learning group.](pone.0224310.g002){#pone.0224310.g002}

![Calibration curve of the prediction model based on the validation group.](pone.0224310.g003){#pone.0224310.g003}

Harrell\'s C was 71.5% in the learning group. The AUCs of cox model for the learning group for 5, 10, and 15 years were 0.742, 0.755, and 0.762, and for the validation group 0.766, 0.763, and 0.770, respectively. The ROC curves are presented in [S1](#pone.0224310.s001){ref-type="supplementary-material"} and [S2](#pone.0224310.s002){ref-type="supplementary-material"} Figs.

[Fig 4](#pone.0224310.g004){ref-type="fig"} shows a nomogram based on the cox model with prediction of mortality 5, 10, and 15 years after surgery. [Table 3](#pone.0224310.t003){ref-type="table"} indicates the points for each variable in the nomogram and [Table 4](#pone.0224310.t004){ref-type="table"} shows the total points for several main probabilities of mortality.

![Nomogram presenting the prediction model for 5, 10 and 15-year survival.\
Nomogram shows cox model for prediction of mortality 5, 10, and 15 years after surgery. Each parameter has corresponding values (points) that appear in the upper toolbar (also in [Table 3](#pone.0224310.t003){ref-type="table"}). Summarized total points should be applied on the bottom scale (\"Total Point\") to obtain probability of mortality 5, 10 and 15 years after surgery. DM---Diabetes mellitus; COPD---Chronic obstructive lung disease; CHF---Congestive heart failure; CRF---Chronic renal failure; MI---Myocardial infarction; EF---Ejection fraction; IABP---Intra-aortic balloon; PVD---Peripheral vascular disease.](pone.0224310.g004){#pone.0224310.g004}

10.1371/journal.pone.0224310.t003

###### Points that each variable represents in the nomogram.

![](pone.0224310.t003){#pone.0224310.t003g}

  Predictor     Points
  ------------- --------
  Age (years)   
  \<55          0
  55--59        29
  60--64        38
  65--69        58
  70--74        68
  75--79        90
  80+           100
  DM            14
  COPD          21
  CHF           14
  CRF           19
  Old MI        11
  EF≤30%        18
  IABP          22
  PVD           22

DM---Diabetes mellitus; COPD---Chronic obstructive lung disease; CHF---Congestive heart failure; CRF---Chronic renal failure; MI---Myocardial infarction; EF---Ejection fraction; IABP---Intra-aortic balloon; PVD---Peripheral vascular disease

10.1371/journal.pone.0224310.t004

###### Predicted mortality for 5, 10, and 15 years after surgery, according to sum of points on the nomogram.

![](pone.0224310.t004){#pone.0224310.t004g}

  Probability of mortality   Years after surgery         
  -------------------------- --------------------- ----- -----
  5%                         32                          
  10%                        67                    22    
  15%                        88                    44    6
  20%                        104                   59    22
  25%                        116                   71    34
  30%                        127                   82    45
  35%                        136                   91    54
  40%                        144                   100   62
  45%                        152                   107   70
  50%                        159                   115   77
  55%                        166                   121   84
  60%                        173                   128   91
  65%                        179                   135   98
  70%                        186                   142   104
  75%                        193                   148   111
  80%                                              156   119
  85%                                              164   127
  90%                                              173   136
  95%                                              186   149

Discussion {#sec017}
==========

Several risk scores were developed to evaluate the risk associated with early mortality after CABG \[[@pone.0224310.ref017]--[@pone.0224310.ref019]\], and several risk scores were also developed to evaluate long term mortality \[[@pone.0224310.ref007]--[@pone.0224310.ref015]\]. However, these models evaluated late mortality of up to 8 years post-operatively. Similar prediction models were also developed in other medical areas, for example: a model to predict mortality in patients with prostate cancer \[[@pone.0224310.ref020]\], a model to predict pulmonary hypertension based on findings of CT pulmonary angiography \[[@pone.0224310.ref021]\], and a model to predict early relapse in patients with Crohn\`s disease \[[@pone.0224310.ref022]\].

Several studies have shown significant benefit of BITA grafting compared to SITA grafting \[[@pone.0224310.ref016], [@pone.0224310.ref023]--[@pone.0224310.ref026]\]. Therefore, models that were built according to patients who mostly underwent SITA grafting are limited in their applicability to predict outcomes of patients who underwent BITA grafting.

In the current study, we tried to develop a model that identifies predictors for long term survival, up to fifteen years after BITA grafting and use it as a simple validated prediction tool. This model may provide a longer prediction period than the previous ones \[[@pone.0224310.ref007]--[@pone.0224310.ref015]\], and also specifically addresses the sub group of patients treated with BITA, who were not included in previous studies.

In the current study, we divided all BITA patients operated in our department between 1966 and 2011 into two groups: One thousand four hundred and sixty-eight were the learning group and 1,467 were the validation group. The two groups had similar overall mortality and similar 5, 10, and 15-year survival.

Older age, DM, COPD, CHF, CRF, old MI, EF≤30%, pre-operative intra-aortic balloon, and PVD, were significant predictors for mortality in the current model. A previous model proposed by Wu et al. \[[@pone.0224310.ref007]\] for prediction of 7-year mortality after CABG included age, body mass index (BMI), EF, hemodynamic stability, left main coronary artery disease, CVD, PVD, CHF, malignant ventricular arrhythmia, COPD, DM, CRF, and previous CABG. Another previous model proposed by MacKenzie et al. \[[@pone.0224310.ref014]\] for prediction of 8-year mortality after CABG included age, BMI, COPD, DM, EF, gender, left main coronary artery disease, old MI, number of diseased vessels, prior CABG, PVD, CRF, patients\' status (elective/urgent, salvage, emergent), and white blood cells. Patients with malignant ventricular arrhythmia were not referred to BITA in our center and therefore this risk factor was not included in our model. Additionally, data on patients\' BMI was not available for a large proportion of the charts, and was therefore waived. However, most of the variables that were included in these previous studies were also included as potential predictors in our study.

The Harrell\'s C in the current model was close to that reported by MacKenzie et al \[[@pone.0224310.ref014]\]. The AUCs of the cox model for 5, 10, and 15-year survival for the learning group ranged between 0.742 and 0.762, and for the validation group between 0.766--0.770, respectively. The AUCs value for 5 years were close to that reported in previous studies \[[@pone.0224310.ref007],[@pone.0224310.ref014]\].

This study has several limitations. First, in order to evaluate long term outcome, we had to use data on patients who underwent CABG between 1996 and 2011. There was an improvement in patient management which may only be partially reflected in the cohort. Second, due to the historical nature of the study, data on BMI and blood tests were available only in part of the patients\' charts, and therefore these variables were not included as potential predictors. Third, we did not have data on specific cause of death and therefore all-cause mortality was used instead. Lastly, supplemental angiographic data that could have been included in the model was not available.

In conclusion, a simple to use validated model can be used to predict 5, 10, and 15-year mortality after CABG using the BITA grafting technique.

Supporting information {#sec018}
======================

###### ROC curves of the Cox model for 5, 10, and 15-year survival in the learning group.

(TIF)

###### 

Click here for additional data file.

###### ROC curves of the Cox model for 5, 10, and 15-year survival in the validation group.

(TIF)

###### 

Click here for additional data file.
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CABG

:   Coronary artery bypass grafting

LITA

:   Left internal thoracic artery

LAD

:   Left anterior descending

SVG

:   Saphenous vein graft

BITA

:   Bilateral internal thoracic arteries

SITA

:   Single internal thoracic artery

DM

:   Diabetes mellitus

COPD

:   Chronic obstructive lung disease

CRF

:   Chronic renal failure

CVD

:   Cerebral-vascular disease

PVD

:   Peripheral vascular disease

ND

:   Neurologic dysfunction

CHF

:   Congestive heart failure

MI

:   Myocardial infarction

EF

:   Ejection fraction

PCI

:   Percutaneous transluminal coronary angioplasty

LM

:   Left main

IABP

:   Intra-aortic balloon

SD

:   Standard deviation

BMI

:   Body mass index
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